100 related articles for article (PubMed ID: 688279)
1. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.
Patton TF; Himmelstein KJ; Belt R; Bannister SJ; Sternson LA; Repta AJ
Cancer Treat Rep; 1978 Sep; 62(9):1359-62. PubMed ID: 688279
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).
Belt RJ; Himmelstein KJ; Patton TF; Bannister SJ; Sternson LA; Repta AJ
Cancer Treat Rep; 1979; 63(9-10):1515-21. PubMed ID: 498151
[TBL] [Abstract][Full Text] [Related]
3. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
Litterst CL; LeRoy AF; Guarino AM
Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
[TBL] [Abstract][Full Text] [Related]
5. Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).
Casper ES; Kelsen DP; Alcock NW; Young CW
Cancer Treat Rep; 1979; 63(11-12):2023-5. PubMed ID: 575066
[No Abstract] [Full Text] [Related]
6. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
Hayata S; Hitoshi T; Kiyokawa K; Esaki S; Mihashi S; Hirano M
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2356-61. PubMed ID: 6541891
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
Horiuchi M; Inuyama Y; Kohno N; Mashino S; Fujii M
Gan To Kagaku Ryoho; 1982 Apr; 9(4):632-7. PubMed ID: 6892197
[TBL] [Abstract][Full Text] [Related]
8. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
Shindo K; Oikawa N; Atsumi Y; Chida S; Tuburaya T; Yajima A
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):639-44. PubMed ID: 3827260
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
Cano JP; Catalin J; Rigault JP; Bues-Charbit M; Placidi M; Raybaud C; Bernard JL
Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945
[TBL] [Abstract][Full Text] [Related]
10. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
[TBL] [Abstract][Full Text] [Related]
11. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM
Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.
Forastiere AA; Belliveau JF; Goren MP; Vogel WC; Posner MR; O'Leary GP
Cancer Res; 1988 Jul; 48(13):3869-74. PubMed ID: 3378222
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic study of cisplatin and sodium thiosulfate in two-route-infusion chemotherapy].
Ikeda K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1026-31. PubMed ID: 3963847
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of vindesine infusion.
Rahmani R; Kleisbauer JP; Cano JP; Martin M; Barbet J
Cancer Treat Rep; 1985; 69(7-8):839-44. PubMed ID: 2410121
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic evaluation of continuous infusion cisplatin].
Hiura M; Takenawa J; Ryoji O; Taki Y; Hyashi T; Kiriyama T
Hinyokika Kiyo; 1989 Jun; 35(6):955-61. PubMed ID: 2801396
[TBL] [Abstract][Full Text] [Related]
16. [Investigations on the pharmacokinetics of apalcillin in man].
Busch U; Heinzel G; Seyfarth H; Mielenz H
Arzneimittelforschung; 1982; 32(9):1131-5. PubMed ID: 6890838
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
Fracasso ME; Apostoli P; Benoni G; Bonetti A; Griso C; Leone R
Drugs Exp Clin Res; 1987; 13(6):367-72. PubMed ID: 3652926
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II).
Vermorken JB; van der Vijgh WJ; Pinedo HM
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):319-28. PubMed ID: 7190316
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.
Gullo JJ; Litterst CL; Maguire PJ; Sikic BI; Hoth DF; Woolley PV
Cancer Chemother Pharmacol; 1980; 5(1):21-6. PubMed ID: 6161715
[TBL] [Abstract][Full Text] [Related]
20. Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II).
Dumas M; d'Athis P; de Gislain C; Escousse A; Guerrin J; Autissier N
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):430-3. PubMed ID: 4044076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
